Is the HPV-test more cost-effective than cytology in cervical cancer screening? An economic analysis from a middle-income country.
<h4>Objective</h4>To report a modelling study using local health care costs and epidemiological inputs from a population-based program to access the cost-effectiveness of adopting hrHPV test.<h4>Methods</h4>A cost-effectiveness analysis based on a microsimulation dynamic Mark...
Guardado en:
Autores principales: | Diama Bhadra Vale, Marcus Tolentino Silva, Michelle Garcia Discacciati, Ilana Polegatto, Julio Cesar Teixeira, Luiz Carlos Zeferino |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0b52e42165d741e39c652985dbb60d3f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Organization of cervical cancer screening with DNA–HPV testing impact on early–stage cancer detection: a population–based demonstration study in a Brazilian city
por: Julio Cesar Teixeira, et al.
Publicado: (2022) -
The role of HPV testing in reducing the burden of cervical cancer in low and middle income countries
por: T. Randall, et al.
Publicado: (2015) -
A very rare case of HPV-53-related cervical cancer, in a 79-year-old woman with a previous history of negative Pap cytology
por: Zappacosta R, et al.
Publicado: (2014) -
Assessing survival rate of HPV-positive and HPV-negative cervical cancer patients
por: M. K. Ibragimova, et al.
Publicado: (2019) -
A very rare case of HPV-53-related cervical cancer, in a 79-year-old woman with a previous history of negative Pap cytology [corrigendum]
por: Zappacosta R, et al.
Publicado: (2014)